Boiron SA (EPA:BOI)

Market Cap	428.85M
Revenue (ttm)	487.56M
Net Income (ttm)	11.34M
Shares Out	17.36M
EPS (ttm)	0.65
PE Ratio	37.83
Forward PE	15.82
Dividend	1.20 (4.86%)
Ex-Dividend Date	Jun 3, 2025

Volume	492
Average Volume	1,426
Open	25.00
Previous Close	24.70
Day's Range	24.55 - 25.00
52-Week Range	22.90 - 36.35
Beta	0.25
RSI	55.06
Earnings Date	Apr 22, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.